Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01733667Not ApplicableCompleted

A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery

Role: lead

NCT00957502Not ApplicableCompleted

ENTact™ Septal Stapler Shelf Life Extension

Role: lead

NCT00896883Not ApplicableCompleted

Evaluation of the Middle Turbinate Implant for Affixing the Middle Turbinate to the Nasal Septum

Role: lead

NCT00740480Completed

Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty

Role: lead

All 4 trials loaded